Verve Therapeutics Inc. Made Big Gain
Tue, Jul 19, 2022 at 07:09 PM
Verve Therapeutics Inc. (VERV:NASDAQ) shot up at $32.29, representing a gain of 22.7%. On Tue, Jul 19, 2022, VERV:NASDAQ touched a New 2-Week High of $32.29. The stock got featured on our News Catalysts scanner on Tue, Jul 12, 2022 at 06:40 AM in the 'INVESTOR UPDATE' category. From Tue, Jul 05, 2022, the stock recorded 70.00% Up Days and 72.73% Green Days
About Verve Therapeutics Inc. (VERV:NASDAQ)
Verve Therapeutics Inc is a genetic medicines company pioneering the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.
Top 10 Gainers:
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 45.31%
- Sidus Space Inc. (SIDU:NASDAQ), 40.64%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 32.17%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 27.4%
- Power REIT (PW:NYSEMKT), 26.86%
- Verve Therapeutics Inc. (VERV:NASDAQ), 22.73%
- Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 22.59%
- Silvergate Capital Corporation (SI:NYSE), 22.37%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 20.63%
- DermTech, Inc. (DMTK:NASDAQ), 20.41%